342 related articles for article (PubMed ID: 35262564)
21. In vitro evaluation of anti-fungal activity of tropicamide against strains of Candida spp. resistant to fluconazole in planktonic and biofilm form.
Machado CB; Rocha da Silva C; Daiana Barroso F; Campos RDS; Valente Sá LGDA; S Aires do Nascimento FB; Cavalcanti BC; Vitoriano Nobre Júnior H; Andrade Neto JB
J Mycol Med; 2021 Mar; 31(1):101080. PubMed ID: 33278803
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
23. Increasing Susceptibility of Drug-Resistant
Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
25. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
26. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
27. Small molecule II-6s synergises with fluconazole against Candida albicans.
Yang S; Peng X; Ren B; Luo Y; Xu X
Int J Antimicrob Agents; 2023 Jul; 62(1):106820. PubMed ID: 37086819
[TBL] [Abstract][Full Text] [Related]
28. Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.
Sari S; Koçak E; Kart D; Özdemir Z; Acar MF; Sayoğlu B; Karakurt A; Dalkara S
Int Microbiol; 2021 Jan; 24(1):93-102. PubMed ID: 32889579
[TBL] [Abstract][Full Text] [Related]
29. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K
BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244
[TBL] [Abstract][Full Text] [Related]
30. Bioactive triterpenoids from Solanum torvum fruits with antifungal, resistance modulatory and anti-biofilm formation activities against fluconazole-resistant candida albicans strains.
Harley BK; Neglo D; Tawiah P; Pipim MA; Mireku-Gyimah NA; Tettey CO; Amengor CD; Fleischer TC; Waikhom SD
PLoS One; 2021; 16(12):e0260956. PubMed ID: 34962953
[TBL] [Abstract][Full Text] [Related]
31. Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Nagy F; Tóth Z; Bozó A; Czeglédi A; Rebenku I; Majoros L; Kovács R
Med Mycol; 2019 Jul; 57(5):573-581. PubMed ID: 30339227
[TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
33. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of cisatracurium against fluconazole-resistant
do Nascimento FB; Valente Sá LG; de Andrade Neto JB; Cabral VP; Rodrigues DS; Barbosa AD; Moreira LE; Oliveira LC; Silva A; Lima IS; Silva J; Marinho ES; Santos HS; Cavalcanti BC; Morais MO; Júnior HV; Silva CR
Future Microbiol; 2023 Jul; 18():649-660. PubMed ID: 37522164
[No Abstract] [Full Text] [Related]
35. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
36. Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
Madhavan P; Jamal F; Pei CP; Othman F; Karunanidhi A; Ng KP
Mycopathologia; 2018 Jun; 183(3):499-511. PubMed ID: 29380188
[TBL] [Abstract][Full Text] [Related]
37. Variable antifungal activity of curcumin against planktonic and biofilm phase of different candida species.
Narayanan VS; Muddaiah S; Shashidara R; Sudheendra US; Deepthi NC; Samaranayake L
Indian J Dent Res; 2020; 31(1):145-148. PubMed ID: 32246698
[TBL] [Abstract][Full Text] [Related]
38. Phytolacca tetramera berries extracts and its main constituents as potentiators of antifungal drugs against Candida spp.
Butassi E; Blanc AR; Svetaz LA
Phytomedicine; 2024 Jul; 130():155569. PubMed ID: 38795695
[TBL] [Abstract][Full Text] [Related]
39. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
[TBL] [Abstract][Full Text] [Related]
40. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
